Copyright © 2025 Authors retain the copyright of this article. This article is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
@article{166679, author = {LAVANYA YAIDIKAR}, title = {NEUROINFLAMMATION AND NEURODEGENERATIVE DISEASES}, journal = {International Journal of Innovative Research in Technology}, year = {2024}, volume = {11}, number = {2}, pages = {1546-1552}, issn = {2349-6002}, url = {https://ijirt.org/article?manuscript=166679}, abstract = {Oxidative stress is associated with the onset and progression of various diseases, particularly neurodegenerative conditions. This study reviews the research linking oxidative stress to the pathogenesis of amyotrophic lateral sclerosis (ALS), Parkinson's disease, Alzheimer's disease, and Huntington's disease, focusing on the role of reactive oxygen species. It also examines how oxidative stress influences the inflammatory response. Although oxidative stress and neuroinflammation are distinct clinical phenomena, they are interconnected and impact each other. A thorough understanding of the pathways involved in the initiation and progression of neurodegenerative disorders is essential for developing effective treatments. This paper discusses common antioxidants, both enzymatic and non-enzymatic, as potential therapeutic options for these disorders due to their ability to modulate oxidative stress and mitigate symptoms of neurodegenerative diseases.}, keywords = {Alzheimer's disease; chronic inflammation; interleukin-18; interleukin-1β; NLRP3 inflammasome; neuroinflammation; Parkinson's disease; type 2 diabetes mellitus.}, month = {July}, }
Cite This Article
Submit your research paper and those of your network (friends, colleagues, or peers) through your IPN account, and receive 800 INR for each paper that gets published.
Join NowNational Conference on Sustainable Engineering and Management - 2024 Last Date: 15th March 2024
Submit inquiry